Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CTMX CytomX Therapeutics, Inc.
$5.38 -1.84% -0.10
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CTMX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 901.4M
Enterprise value 804.0M
Trailing PE 18.083334
Forward PE -14.756285
PEG Ratio -0.07911458625
Enterprise to EBITDA 32.783
Enterprise to revenue 7.076
Price to book MRQ 8.333333
Price to sales TTM 8.089228

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 113.6M
EBITDA 26.8M
Diluted EPS TTM 0.3
Total Cash (MRQ) 143.6M
Current ratio (MRQ) 3.637
Operating Cash Flow (TTM) -72252000

CTMX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CTMX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.